A newly published study suggests the long-acting buprenorphine formulation BUP-XR is more effective than placebo in helping patients struggling with addiction to opioids. BUP-XR is…
Read More
Nano-painkiller lasts longer and is less addictive than opioids
A team of researchers from Université Paris-Saclay and Université Paris Descartes has developed a nano-drug that has been found to reduce pain in rodents. In…
Read More
Poor whites bear the brunt of U.S. opioid crisis, studies find
(HealthDay)—America’s ongoing opioid epidemic has struck poor whites harder than any other group, and a new study argues that racism likely played a role in…
Read More
NSAID pretreatment impairs immune response in heart failure, worsens heart and kidney damage
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation. However, prolonged use raises the risk of heart and…
Read More
Care following opioid overdoses in West Virginia falls short
Only a small fraction of people who had non-fatal opioid overdoses in West Virginia received treatment in the aftermath, a new study led by researchers…
Read More
Many users prefer medical marijuana over prescription drugs
As more states legalize cannabis consumption, many more people will likely use medical marijuana as a supplement to or substitution for prescription drugs, says a…
Read More
Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate
Saint-Herblain (France), December 21, 2018 – Valneva SE ("Valneva"), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announced today…
Read More
Rodin Therapeutics Announces Initiation of Phase 1 Clinical Trial of a Selective CoREST Inhibitor to Treat Neurologic Diseases
Cambridge, Mass. – December 12, 2018 – Rodin Therapeutics today announced the initiation of a Phase 1 clinical trial of the company’s lead candidate, RDN-929,…
Read More